Pathophysiology of articular chondrocalcinosis--role of ANKH. (Q37811887)

23 August 2017

Pathophysiology of articular chondrocalcinosis--role of ANKH. (English)

1 reference

23 August 2017

1 reference

2

Michael Doherty

1 reference

23 August 2017

Abhishek Abhishek

1

1 reference

PubMed ID

21102543

23 August 2017

language of work or name

English

0 references

publication date

23 November 2010

1 reference

Nature Reviews Rheumatology

23 August 2017

1 reference

23 August 2017

7

1 reference

23 August 2017

2

1 reference

23 August 2017

96-104

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2010.182

23 August 2017

0 references

cites work

Calcium pyrophosphate dihydrate crystal deposition disease—1975

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Relative risk of knee chondrocalcinosis in siblings of index cases with pyrophosphate arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Prevalence of articular chondrocalcinosis in elderly subjects in a rural area of Catalonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Lower prevalence of chondrocalcinosis in Chinese subjects in Beijing than in white subjects in the United States: the Beijing Osteoarthritis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Calcium pyrophosphatase dihydrate (CPPD) crystal deposition disease in a teaching hospital in Kuwait

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Localised chondrocalcinosis in post-meniscectomy knees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Articular cartilage mineralization in osteoarthritis of the hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Calcification of articular cartilage in human osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Frequency of chondrocalcinosis of the knees in asymptomatic hyperuricaemia and rheumatoid arthritis: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

CPPD crystal deposition disease in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Localisation of a gene for chondrocalcinosis to chromosome 5p

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Hereditary diffuse articular chondrocalcinosis. Dominant manifestation without close linkage with the HLA system in a large pedigree

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Mutations in ANKH cause chondrocalcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Familial calcium pyrophosphate dihydrate deposition disease. A Tunisian kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Familial articular chondrocalcinosis in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Articular Cartilage Vesicles Generate Calcium Pyrophosphate Dihydrate-Like Crystals in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Articular cartilage vesicles contain RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

"Crystal clear"-sonographic assessment of gout and calcium pyrophosphate deposition disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Metabolism of inorganic pyrophosphate (PPi)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Biochemical and genetic analysis of ANK in arthritis and bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

ATP-induced chondrocalcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Expression of cartilage intermediate layer protein/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

One of two chondrocyte‐expressed isoforms of cartilage intermediate‐layer protein functions as an insulin‐like growth factor 1 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Nature of phosphate substrate as a major determinant of mineral type formed in matrix vesicle-mediated in vitro mineralization: An FTIR imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Osteopontin promotes pathologic mineralization in articular cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Role of the mouse ank gene in control of tissue calcification and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Diseases associated with CPPD deposition disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Phosphodiesterase activity of alkaline phosphatase in ATP-initiated Ca(2+) and phosphate deposition in isolated chicken matrix vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Role of the progressive ankylosis gene (ank) in cartilage mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

The ANKH gene and familial calcium pyrophosphate dihydrate deposition disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Extracellular matrix changes regulate calcium crystal formation in articular cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Transglutaminase contributes to CPPD crystal formation in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Joint lavage and pseudogout.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Recent developments in crystal-induced inflammation pathogenesis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Gout-associated uric acid crystals activate the NALP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Calcium pyrophosphate dihydrate crystal-induced inhibition of neutrophil apoptosis: involvement of Bcl-2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Monosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Inhibition of TNF-alpha-induced neutrophil apoptosis by crystals of calcium pyrophosphate dihydrate is mediated by the extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways up-stream of caspase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Contribution of calcium-containing crystals to cartilage degradation and synovial inflammation in osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Comparison of sodium urate and calcium pyrophosphate crystal phagocytosis by polymorphonuclear leukocytes. Effects of crystal size and other factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Evidence for a causal relationship between the structure, size, and load of calcium pyrophosphate dihydrate crystals, and attacks of pseudogout

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Treating difficult crystal pyrophosphate dihydrate deposition disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Successful treatment of resistant pseudogout with anakinra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Chronic arthritis associated with the presence of intrasynovial rubella virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Mercaptopyruvate inhibits tissue-nonspecific alkaline phosphatase and calcium pyrophosphate dihydrate crystal dissolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Phosphocitrate as a potential therapeutic strategy for crystal deposition disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Transforming growth factor beta-1 stimulates articular chondrocyte elaboration of matrix vesicles capable of greater calcium pyrophosphate precipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Developmental and TGF-beta-mediated regulation of Ank mRNA expression in cartilage and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

The CPPDD-associated ANKH M48T mutation interrupts the interaction of ANKH with the sodium/phosphate cotransporter PiT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) affects tissue non-specific Alkaline Phosphatase (TNAP) activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Low incidence of calcium pyrophosphate dihydrate crystal deposition in rheumatoid arthritis, with modification of radiographic features in coexistent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

EFFECT OF INTRA-ARTICULAR YTTRIUM-90 ON CHRONIC PYROPHOSPHATE ARTHROPATHY OF THE KNEE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Comparison of characteristics of patients with and without calcium pyrophosphate dihydrate crystal deposition disease who underwent total knee replacement surgery for osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Hypomagnesemia and chondrocalcinosis in Bartter's and Gitelman's syndrome: review of the pathogenetic mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Hypomagnesemia associated with chondrocalcinosis: a cross-sectional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

CPPD complicating other forms of inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Familial articular chondrocalcinosis in Quebec

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Musculoskeletal disease burden of hereditary hemochromatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Calcium pyrophosphate dihydrate crystal deposition in synovium. Relationship to collagen fibers and chondrometaplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Calcium pyrophosphate crystal deposition. An in vitro study using a gelatin matrix model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Inorganic pyrophosphate generation and disposition in pathophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Release of Pyrophosphate by Normal Mammalian Articular Hyaline and Fibrocartilage in Organ Culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

A comparison of the effect of transforming growth factor beta 1 on pyrophosphate elaboration from various articular tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Articular chondrocalcinosis. Microanalysis of pyrophosphate (PPi) in synovial fluid and plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Hereditary joint disorder in progressive ankylosis (ank/ank) mice I. association of calcium hydroxyapatite deposition with inflammatory arthropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Promotion of articular cartilage matrix vesicle mineralization by type I collagen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Chondrocytes that accumulate proteoglycans and inorganic pyrophosphate in the pathogenesis of chondrocalcinosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

The transglutaminase, Factor XIIIA, is present in articular chondrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Participation of transglutaminase in the activation of latent transforming growth factor beta1 in aging articular cartilage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Acceleration of experimental lapine osteoarthritis by calcium pyrophosphate microcrystalline synovitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Management of crystal arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Intravenous colchicine in the treatment of acute pseudogout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Effect of glycosaminoglycans on calcium pyrophosphate crystal formation in collagen gels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Variations in site and levels of expression of chondrocyte nucleotide pyrophosphohydrolase with aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Retinoic acid stimulates pyrophosphate elaboration by cartilage and chondrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta1-stimulated chondrocytes and cartilage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

Evidence of a generalized metabolic defect in patients with hereditary chondrocalcinosis. Increased inorganic pyrophosphate in cultured fibroblasts and lymphoblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.182

The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles.

31 March 2020

1 reference

12 December 2020

The high prevalence of pathologic calcium crystals in pre-operative knees

1 reference

12 December 2020

Differential effects of aging on human chondrocyte responses to transforming growth factor beta: increased pyrophosphate production and decreased cell proliferation

1 reference

12 December 2020

Association between crystals and cartilage degeneration in the ankle.

1 reference

12 December 2020

Familial chondrocalcinosis in the Spanish population

1 reference

12 December 2020

Characterization of an additional articular cartilage vesicle fraction that generates calcium pyrophosphate dihydrate crystals in vitro

1 reference

12 December 2020

Prospective use of intramuscular triamcinolone acetonide in pseudogout

1 reference

12 December 2020

The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study.

1 reference

12 December 2020

Hereditary chondrocalcinosis in a Tunisian family.

1 reference

12 December 2020

Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions

1 reference

12 December 2020

A histological study of calcium pyrophosphate dihydrate crystal-deposition disease

1 reference

12 December 2020

Linkage of early-onset osteoarthritis and chondrocalcinosis to human chromosome 8q

1 reference

12 December 2020

Probenecid inhibits transforming growth factor-beta 1 induced pyrophosphate elaboration by chondrocytes

1 reference

12 December 2020

HLA-antigens in a Tunisian familial chondrocalcinosis

1 reference

12 December 2020

The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals

1 reference

12 December 2020

Colchicine prophylaxis in pseudogout

1 reference

12 December 2020

Regulation of alkaline phosphatase: implications for calcium pyrophosphate dihydrate crystal dissolution and other alkaline phosphatase functions

1 reference

12 December 2020

A histologic and immunohistochemical study of calcium pyrophosphate dihydrate crystal deposition disease

1 reference

12 December 2020

Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes

1 reference

12 December 2020

Comparison of the efficacy of nonsurgical synovectomy (synoviorthesis) and joint lavage in knee osteoarthritis with effusions

1 reference

12 December 2020

Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD.

1 reference

12 December 2020

ATP release by mechanically loaded porcine chondrons in pellet culture

1 reference

12 December 2020

Calcium pyrophosphate crystal deposition in hyaline cartilage. Ultrastructural analysis and implications for pathogenesis

1 reference

12 December 2020

Prevalence of chondrocalcinosis in Italian subjects from northeastern Italy. The Pro.V.A. (PROgetto Veneto Anziani) study

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2010.182

1 reference

PubMed ID

21102543

Dimensions Publication ID

23 August 2017

0 references

1 reference

PubMed ID

21102543